COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,900 Articles (22,568 medRxiv, 8,332 bioRxiv)

Most recent first Previous |  Page 166: Articles 1651-1660  | Next

Vitamin D levels and COVID-19 severe pneumonia: a prospective case-control study
Cardoso, F. J., Araujo, C. A., Silva Junior, J. R., Guimaraes, A., Taveiro, M. V., Figueiroa, J. N., Alves, J. G.
10.1101/2024.06.10.24308690 — Posted: 2024-06-11
Quantum-classical hybrid approach for codon optimizationand its practical applications
Huh, J., Park, D. K., Chung, Y. K., Lee, D., Lee, J., Kim, J.
10.1101/2024.06.08.598046 — Posted: 2024-06-11
A library-on-library screen reveals the breadth expansion landscape of a broadly neutralizing betacoronavirus antibody
Ornelas, M. Y., Ouyang, W. O., Wu, N. C.
10.1101/2024.06.06.597810 — Posted: 2024-06-10
Evaluating survey techniques in wastewater-based epidemiology for accurate COVID-19 incidence estimation
Murakami, M., Ando, H., Yamaguchi, R., Kitajima, M.
10.1101/2024.06.09.24308677 — Posted: 2024-06-10
Seroprevalence of SARS-CoV-2 and risk factors for infection among children in Uganda: a serial cross-sectional study
Bagala, I., Namuganga, J. F., Nayebare, P., Cuu, G., Katairo, T., Nabende, I., Gonahasa, S., Nassali, M., Tukwasibwe, S., Dorsey, G., Nankabirwa, J. I., Kitaka, S., Kiguli, S., Greenhouse, B., Ssewanyana, I., Kamya, M. R., Briggs, J.
10.1101/2024.06.09.24308673 — Posted: 2024-06-10
Tocilizumab Reduces Hypercoagulation in COVID-19 - Perspectives from The Coagulation and Immunomodulation Covid Assessment (Coag-ImmCovA) Clinical Trial.
Almskog, L. M., Sjostrom, A., Sunden-Cullberg, J., Taxiarchis, A., Agren, A., Freyland, S., Borjesson, M., Wikman, A., Wahlgren, C. M., Wanecek, M., van der Linden, J., Antovic, J., Lampa, J., Magnusson, M.
10.1101/2024.05.31.24308108 — Posted: 2024-06-10
Virological characteristics of the SARS-CoV-2 KP.3, LB.1 and KP.2.3 variants
Kaku, Y., Yo, M. S., Tolentino, J. E., Uriu, K., Okumura, K., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Ito, J., Sato, K.
10.1101/2024.06.05.597664 — Posted: 2024-06-09
Evidence for Behavioral Autorepression in Covid-19 Epidemiological Dynamics
Lewis, D. D., Pablo, M., Chen, X., Simpson, M. L., Weinberger, L.
10.1101/2024.06.07.24308626 — Posted: 2024-06-09
Workplace transmission of SARS-CoV-2 among health-care workers in Malaysia
Chan, Y. Y., Md Zoqratt, M. Z. H., Lau, N.-S., Musa, N., Khalid, M. F., Lim, S. Y., Wan Mohammad, W. M. Z., Rahman, S., Eng, W. W. H., Hussin, Z., Muhammad, A. H., Mohd Zain, M., Sulaiman, S., Mohd Fuzi, N. M. H., Mat Salleh, N. H., Omar, S., Halim, A. S., Deris, Z. Z., Banga Singh, K. K., Harun, A., Samsudin, M. N. F., Chua, W. L., Azmi, N. L., Engku Abd Rahman, E. N. S., Ahmed, N., Yaacob, N. A., Hamidun, A. R., Baharuddin, M. H., Nik Ab. Kadir, M. N., Hj Mahmud, M., Suliman, M. A., Ayub, Q., Hassan, R.
10.1101/2024.06.06.24306328 — Posted: 2024-06-09
Proteome-wide autoantibody screening and holistic autoantigenomic analysis unveil COVID-19 signature of autoantibody landscape
Matsuda, K. M., Kawase, Y., Iwadoh, K., Kurano, M., Yatomi, Y., Okamoto, K., Moriya, K., Kotani, H., Hisamoto, T., Kuzumi, A., Fukasawa, T., Yoshizaki-Ogawa, A., Kono, M., Okamura, T., Shoda, H., Fujio, K., Yamaguchi, K., Okumura, T., Ono, C., Kobayashi, Y., Sato, A., Miya, A., Goshima, N., Uchino, R., Murakami, Y., Matsunaka, H., Imai, H., Sato, S., Raymond, R., Yoshizaki, A.
10.1101/2024.06.07.24308592 — Posted: 2024-06-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).